Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$52.09 - $64.1 $5.45 Million - $6.71 Million
104,700 Added 209.4%
154,700 $8.06 Million
Q2 2023

Aug 11, 2023

BUY
$54.67 - $66.44 $2.73 Million - $3.32 Million
50,000 New
50,000 $3.17 Million
Q1 2022

May 12, 2022

SELL
$38.74 - $62.09 $25,374 - $40,668
-655 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$30.8 - $39.51 $20,174 - $25,879
655 New
655 $22,000

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.85B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Healthcare Of Ontario Pension Plan Trust Fund Portfolio

Follow Healthcare Of Ontario Pension Plan Trust Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Healthcare Of Ontario Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Healthcare Of Ontario Pension Plan Trust Fund with notifications on news.